Not applicableEnded earlyNCT02493491What this trial is testingNeurogenic Dysphonia/Dysphagia RegistryWho this might be right forNeurogenic DysphoniaNeurogenic Dysphagia Merz North America, Inc. 146
Large-scale testing (Phase 3)Ended earlyNCT04378075What this trial is testingEvaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory EpilepsyWho this might be right forMitochondrial DiseasesDrug Resistant EpilepsyLeigh Disease+5 more PTC Therapeutics 68
Early research (Phase 1)Looking for participantsNCT06150716What this trial is testingOrbit Study: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Intrathecally Administered ION356 in Participants With Pelizaeus Merzbacher Disease (PMD)Who this might be right forPelizaeus-Merzbacher Disease Ionis Pharmaceuticals, Inc. 24
Not applicableStudy completedNCT05435404What this trial is testingQualitative Study Patient & Physician Experiences Botox COVID-19Who this might be right forChronic Brain InjuryCerebral StrokeMS (Multiple Sclerosis) East Kent Hospitals University NHS Foundation Trust 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT05893225What this trial is testingMetformin Add-on Clinical Study in Multiple Sclerosis to Evaluate Brain Remyelination And NeurodegenerationWho this might be right forMultiple SclerosisPrimary Progressive Multiple SclerosisSecondary-progressive Multiple Sclerosis University Hospital, Antwerp 120
Not applicableActive Not RecruitingNCT04369976What this trial is testingShort Arm Human Centrifuge Therapeutic Training and Rehabilitation (GRACER1)Who this might be right forMultiple SclerosisStrokePulmonary Disease, Chronic Obstructive+1 more Greek Aerospace Medical Association and Space Research 105
Not applicableNot Yet RecruitingNCT07150520What this trial is testingVR-Based Optokinetic Stimulation in Multiple SclerosisWho this might be right forMultiple Sclerosis Avrasya University 30
Testing effectiveness (Phase 2)Study completedNCT00333138What this trial is testingEfficacy and Safety of FTY720 in Patients With Relapsing Multiple SclerosisWho this might be right forMultiple Sclerosis Novartis 281
Not applicableUnknownNCT01811290What this trial is testingA Pilot Study Assessing the Impact of Gilenya Therapy on Bone Density Change in Relapsing Forms of Multiple SclerosisWho this might be right forMultiple Sclerosis Simnad, Virginia, M.D. 36
Not applicableStudy completedNCT04893590What this trial is testingAdapting MHealth Technology to Improve Patient ActivationWho this might be right forSpinal Cord InjuriesStrokeMultiple Sclerosis Washington University School of Medicine 27
Large-scale testing (Phase 3)Study completedNCT01167426What this trial is testingEvaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) PatientsWho this might be right forMultiple Sclerosis Teva Neuroscience, Inc. 148
Not applicableEnded earlyNCT03387267What this trial is testingVideofluoroscopic Swallowing Study (VFSS)Who this might be right forStrokeParkinson DiseaseMultiple Sclerosis+3 more Société des Produits Nestlé (SPN) 452
Not applicableTemporarily pausedNCT04031469What this trial is testingA Non-Interventional Pilot Study to Explore the Role of Gut Flora in DiseaseWho this might be right forGut MicrobiomeGastrointestinal MicrobiomeAutism+77 more ProgenaBiome 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07085507What this trial is testingSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VT7208 in Healthy Participants and MS PatientsWho this might be right forMultiple Sclerosis Vidya Therapeutics Inc 100
Large-scale testing (Phase 3)Looking for participantsNCT05346354What this trial is testingEfficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSDWho this might be right forNeuromyelitis Optica Spectrum Disorder Alexion Pharmaceuticals, Inc. 12
Testing effectiveness (Phase 2)WithdrawnNCT02715505What this trial is testingSafety and Exploratory Efficacy of HSC835 in Patients With Inherited Metabolic Disorders (IMD)Who this might be right forInherited Metabolic Disorders IMD Novartis Pharmaceuticals
Not applicableEnded earlyNCT02204904What this trial is testingObservational Study to Evaluate Allogeneic HSCT Outcomes for Cerebral Adrenoleukodystrophy (CALD)Who this might be right forX-Linked Adrenoleukodystrophy (X-ALD)Cerebral Adrenoleukodystrophy (CALD)Adrenoleukodystrophy (ALD) Genetix Biotherapeutics Inc. 59
Testing effectiveness (Phase 2)UnknownNCT05541549What this trial is testingStudy Evaluating JCPyV-specific T Cell Therapy for PMLWho this might be right forProgressive Multifocal Leukoencephalopathy Cellevolve Bio Inc 60
Testing effectiveness (Phase 2)Study completedNCT01056471What this trial is testingAutologous Mesenchymal Stem Cells From Adipose Tissue in Patients With Secondary Progressive Multiple SclerosisWho this might be right forAutoimmune DiseasesImmune System DiseasesDemyelinating Diseases+3 more Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud 30
Post-approval studies (Phase 4)Study completedNCT01705236What this trial is testingA 3-year Multi-center Study to Describe Changes of OCT Parameters Under Treatment With Gilenya®Who this might be right forRelapsing Remitting Multiple Sclerosis RRMS Novartis Pharmaceuticals 87